# Study of ZB001 in Chinese Patients With Thyroid Eye Disease

> **NCT05776121** · PHASE1 · COMPLETED · sponsor: **Zenas BioPharma (USA), LLC** · enrollment: 17 (actual)

## Conditions studied

- Thyroid Eye Disease

## Interventions

- **DRUG:** ZB001 for injection
- **DRUG:** ZB001 for injection

## Key facts

- **NCT ID:** NCT05776121
- **Lead sponsor:** Zenas BioPharma (USA), LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-10
- **Primary completion:** 2024-04-17
- **Final completion:** 2024-04-17
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05776121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05776121, "Study of ZB001 in Chinese Patients With Thyroid Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05776121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*